IVABRADINE

IVABRADINE was reported 6950 times

IVABRADINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 METABOLIC CARDIOMYOPATHY 5 0.3571
1 TRACHEAL ATRESIA 8 0.2667
2 PSEUDOHYPOGLYCAEMIA 5 0.2500
3 LIMBAL SWELLING 7 0.2258
4 INAPPROPRIATE SINUS TACHYCARDIA 6 0.2222
5 VENOUS PRESSURE JUGULAR DECREASED 7 0.1842
6 COMPUTERISED TOMOGRAM CORONARY ARTERY ABNORMAL 12 0.1791
7 LUPUS MYOCARDITIS 4 0.1481
8 VIRAL TONSILLITIS 8 0.1429
9 SHRINKING LUNG SYNDROME 9 0.1406
10 ENDOCARDITIS ENTEROCOCCAL 14 0.0986
11 COMPUTERISED TOMOGRAM HEART ABNORMAL 6 0.0732
12 CRUSH SYNDROME 10 0.0709
13 NON-COMPACTION CARDIOMYOPATHY 5 0.0658
14 WERNICKE-KORSAKOFF SYNDROME 4 0.0635
15 VENTRICULAR ENLARGEMENT 10 0.0568
16 ELECTROCARDIOGRAM AMBULATORY ABNORMAL 4 0.0563
17 PULMONARY VASCULAR RESISTANCE ABNORMALITY 4 0.0465
18 VENOUS PRESSURE JUGULAR INCREASED 15 0.0413
19 CARDIAC CONTRACTILITY DECREASED 3 0.0390
20 MITRAL VALVE REPLACEMENT 14 0.0354
21 LEFT VENTRICULAR ENLARGEMENT 8 0.0314
22 ECG SIGNS OF MYOCARDIAL ISCHAEMIA 7 0.0307
23 POSITIVE AIRWAY PRESSURE THERAPY 8 0.0274
24 APALLIC SYNDROME 19 0.0262
25 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 35 0.0259
26 TUBERCULOSIS OF CENTRAL NERVOUS SYSTEM 7 0.0258
27 MEAN ARTERIAL PRESSURE DECREASED 6 0.0237
28 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 16 0.0228
29 ATRIAL ENLARGEMENT 6 0.0221
30 VENTRICULAR DYSFUNCTION 57 0.0219
31 CARDIAC SEPTAL HYPERTROPHY 6 0.0217
32 BREAST ULCERATION 3 0.0216
33 KIDNEY DUPLEX 5 0.0208
34 CARDIAC FAILURE CHRONIC 87 0.0204
35 SENSORIMOTOR DISORDER 10 0.0201
36 CYANOSIS CENTRAL 5 0.0192
37 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 27 0.0192
38 LIPOPROTEIN (A) INCREASED 6 0.0183
39 LOW CARDIAC OUTPUT SYNDROME 6 0.0180
40 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL 8 0.0179
41 DILATED CARDIOMYOPATHY 18 0.0178
42 OESOPHAGEAL OBSTRUCTION 15 0.0173
43 BLOOD LUTEINISING HORMONE INCREASED 4 0.0163
44 DYSPNOEA PAROXYSMAL NOCTURNAL 10 0.0137
45 LEFT VENTRICULAR DILATATION 7 0.0137
46 PHOTOPSIA 86 0.0136
47 LEFT ATRIAL ENLARGEMENT 7 0.0130
48 MACROCEPHALY 5 0.0129
49 LEFT VENTRICULAR FAILURE 43 0.0125
50 LIP PRURITUS 10 0.0117
51 HYPERALDOSTERONISM 4 0.0116
52 BEZOAR 16 0.0116
53 CIRCUMORAL OEDEMA 4 0.0115
54 ATRIAL TACHYCARDIA 24 0.0114
55 AORTIC VALVE REPLACEMENT 14 0.0112
56 MYOGLOBIN BLOOD INCREASED 17 0.0111
57 BLEEDING VARICOSE VEIN 6 0.0111
58 PERIODIC LIMB MOVEMENT DISORDER 4 0.0109
59 CARDIAC HYPERTROPHY 12 0.0108
60 EHLERS-DANLOS SYNDROME 5 0.0108
61 JUGULAR VEIN DISTENSION 6 0.0106
62 ORTHOPNOEA 33 0.0104
63 BLOOD FOLLICLE STIMULATING HORMONE INCREASED 4 0.0102
64 TOXICOLOGIC TEST ABNORMAL 6 0.0099
65 EJECTION FRACTION ABNORMAL 12 0.0098
66 SINUS ARREST 15 0.0096
67 VASCULAR STENT STENOSIS 4 0.0095
68 DYSPNOEA AT REST 27 0.0093
69 CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS 4 0.0089
70 MAST CELL ACTIVATION SYNDROME 12 0.0085
71 CARDIAC VENTRICULAR THROMBOSIS 11 0.0085
72 BRONCHIAL WALL THICKENING 6 0.0083
73 HYDROPS FOETALIS 5 0.0082
74 BODY MASS INDEX INCREASED 11 0.0081
75 TORSADE DE POINTES 63 0.0080
76 VASCULITIC RASH 6 0.0078
77 CONGESTIVE CARDIOMYOPATHY 32 0.0077
78 VENTRICULAR ARRHYTHMIA 28 0.0076
79 SYSTOLIC DYSFUNCTION 8 0.0076
80 HEART FAILURE WITH REDUCED EJECTION FRACTION 4 0.0075
81 VENTRICULAR HYPOKINESIA 24 0.0075
82 CONDUCTION DISORDER 13 0.0071
83 EJECTION FRACTION DECREASED 110 0.0071
84 CARDIORENAL SYNDROME 4 0.0070
85 OESOPHAGEAL HAEMORRHAGE 9 0.0068
86 LARGE FOR DATES BABY 6 0.0068
87 BLOOD PRESSURE SYSTOLIC DECREASED 30 0.0066
88 ELECTROCARDIOGRAM PR PROLONGATION 5 0.0065
89 ASPIRATION PLEURAL CAVITY 5 0.0065
90 FOETAL MALFORMATION 7 0.0064
91 KIDNEY ENLARGEMENT 7 0.0064
92 SINUS BRADYCARDIA 60 0.0062
93 WAIST CIRCUMFERENCE INCREASED 6 0.0058
94 OPHTHALMIC MIGRAINE 4 0.0058
95 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 3 0.0057
96 CONTRAINDICATED DRUG ADMINISTERED 4 0.0057
97 PANCREATIC NEOPLASM 7 0.0057
98 GENITAL RASH 8 0.0056
99 MICROCEPHALY 7 0.0055
100 NEPHROSCLEROSIS 6 0.0054
101 MESOTHELIOMA 7 0.0054
102 BURN ORAL CAVITY 3 0.0052
103 BRAIN NATRIURETIC PEPTIDE INCREASED 16 0.0052
104 OCULOGYRIC CRISIS 11 0.0051
105 VITREOUS DETACHMENT 11 0.0051
106 BRADYCARDIA 258 0.0049
107 SEBORRHOEIC KERATOSIS 7 0.0048
108 MITRAL VALVE INCOMPETENCE 53 0.0047
109 HEART RATE ABNORMAL 26 0.0047
110 HYPERPHOSPHATAEMIA 10 0.0046
111 LANGUAGE DISORDER 10 0.0046
112 PRODUCT NAME CONFUSION 5 0.0046
113 ARTERIAL STENOSIS 4 0.0046
114 DIASTOLIC DYSFUNCTION 14 0.0045
115 CARDIAC FAILURE ACUTE 30 0.0045
116 CATARACT NUCLEAR 3 0.0045
117 LEFT VENTRICULAR DYSFUNCTION 30 0.0045
118 BLOOD PRESSURE SYSTOLIC ABNORMAL 11 0.0044
119 SUPRAVENTRICULAR EXTRASYSTOLES 15 0.0044
120 CARDIAC FAILURE 347 0.0043
121 FEBRILE INFECTION 5 0.0042
122 BUNDLE BRANCH BLOCK LEFT 18 0.0042
123 VENTRICULAR EXTRASYSTOLES 42 0.0040
124 TACHYARRHYTHMIA 10 0.0040
125 HYPERPARATHYROIDISM SECONDARY 10 0.0040
126 POLYHYDRAMNIOS 4 0.0039
127 SINUS TACHYCARDIA 55 0.0039
128 PRESYNCOPE 93 0.0038
129 SINUS NODE DYSFUNCTION 7 0.0038
130 ANGINA PECTORIS 109 0.0038
131 PNEUMONIA FUNGAL 15 0.0038
132 VENTRICULAR FIBRILLATION 42 0.0038
133 IMPLANTABLE DEFIBRILLATOR INSERTION 5 0.0038
134 VENTRICULAR TACHYCARDIA 62 0.0038
135 ACUTE PULMONARY OEDEMA 21 0.0037
136 LEFT VENTRICULAR HYPERTROPHY 16 0.0037
137 DEREALISATION 8 0.0037
138 PULMONARY ARTERIAL PRESSURE INCREASED 6 0.0037
139 SIALOADENITIS 5 0.0037
140 TRICUSPID VALVE INCOMPETENCE 29 0.0036
141 EXERCISE TOLERANCE DECREASED 21 0.0036
142 RIGHT VENTRICULAR DYSFUNCTION 4 0.0036
143 MYOCARDIAL NECROSIS MARKER INCREASED 6 0.0036
144 ECHOCARDIOGRAM ABNORMAL 5 0.0036
145 ELECTROCARDIOGRAM ABNORMAL 28 0.0036
146 CARDIAC DYSFUNCTION 13 0.0035
147 PERSONALITY DISORDER 9 0.0034
148 AUTONOMIC NERVOUS SYSTEM IMBALANCE 10 0.0034
149 URINARY HESITATION 8 0.0033
150 MULTIMORBIDITY 4 0.0033
151 BRONCHIAL HYPERREACTIVITY 4 0.0033
152 ATRIOVENTRICULAR BLOCK SECOND DEGREE 10 0.0033
153 HYPERTROPHIC CARDIOMYOPATHY 5 0.0032
154 HYPERURICAEMIA 13 0.0032
155 FEMORAL NECK FRACTURE 16 0.0031
156 PARAPLEGIA 9 0.0031
157 CARDIOMYOPATHY 46 0.0031
158 CLEFT PALATE 6 0.0031
159 CONCOMITANT DISEASE AGGRAVATED 19 0.0031
160 ISCHAEMIC CARDIOMYOPATHY 9 0.0029
161 AMYLOIDOSIS 5 0.0029
162 OLIGURIA 18 0.0029
163 ABSCESS JAW 3 0.0029
164 DISCHARGE 4 0.0029
165 NEONATAL RESPIRATORY DISTRESS SYNDROME 10 0.0028
166 DEVICE INFUSION ISSUE 7 0.0028
167 PULMONARY OEDEMA 126 0.0028
168 GLOMERULAR FILTRATION RATE DECREASED 34 0.0028
169 COMA SCALE ABNORMAL 8 0.0028
170 HAEMODYNAMIC INSTABILITY 21 0.0028
171 ARRHYTHMIA SUPRAVENTRICULAR 3 0.0027
172 FOETAL DEATH 14 0.0027
173 ATRIOVENTRICULAR BLOCK COMPLETE 18 0.0027
174 HYPERTENSIVE HEART DISEASE 5 0.0027
175 CHRONIC GASTRITIS 6 0.0027
176 ORTHOSTATIC HYPOTENSION 46 0.0026
177 ELECTROCARDIOGRAM QT PROLONGED 94 0.0026
178 SUPRAVENTRICULAR TACHYCARDIA 24 0.0025
179 HEART RATE DECREASED 88 0.0025
180 TOTAL LUNG CAPACITY DECREASED 4 0.0025
181 CARDIAC DEATH 3 0.0025
182 ANGINA UNSTABLE 16 0.0025
183 OXYGEN THERAPY 4 0.0024
184 TROPONIN I INCREASED 4 0.0024
185 OLIGOHYDRAMNIOS 8 0.0024
186 MALIGNANT MELANOMA 32 0.0024
187 CORONARY ARTERY STENOSIS 12 0.0024
188 ATRIAL FLUTTER 19 0.0024
189 CEREBELLAR INFARCTION 4 0.0024
190 MYOCLONUS 28 0.0023
191 SUDDEN CARDIAC DEATH 8 0.0023
192 SERUM FERRITIN DECREASED 4 0.0023
193 HYPOPNOEA 8 0.0023
194 VERTIGO POSITIONAL 4 0.0023
195 CARDIOACTIVE DRUG LEVEL INCREASED 3 0.0023
196 CHEST X-RAY ABNORMAL 7 0.0023
197 LUNG OPACITY 6 0.0023
198 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 5 0.0023
199 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 4 0.0022
200 HYPOTENSION 450 0.0022
201 CARDIAC ABLATION 4 0.0022
202 ELECTROLYTE IMBALANCE 26 0.0022
203 POLYMYALGIA RHEUMATICA 7 0.0022
204 EYE MOVEMENT DISORDER 15 0.0022
205 ISCHAEMIC STROKE 39 0.0022
206 THROMBOCYTOSIS 8 0.0022
207 IRON DEFICIENCY ANAEMIA 20 0.0022
208 PRODUCT ADMINISTRATION INTERRUPTED 17 0.0022
209 OEDEMA MOUTH 7 0.0021
210 STATUS EPILEPTICUS 24 0.0021
211 DYSPNOEA EXERTIONAL 79 0.0021
212 DRUG INTERACTION 332 0.0021
213 POTENTIATING DRUG INTERACTION 7 0.0021
214 BRONCHITIS CHRONIC 5 0.0020
215 CONTRAINDICATED PRODUCT ADMINISTERED 62 0.0020
216 CONCOMITANT DISEASE PROGRESSION 4 0.0020
217 BICYTOPENIA 4 0.0020
218 ACUTE MYOCARDIAL INFARCTION 60 0.0020
219 BLOOD POTASSIUM INCREASED 33 0.0020
220 BREATH SOUNDS ABNORMAL 10 0.0020
221 FUNCTIONAL GASTROINTESTINAL DISORDER 7 0.0020
222 CARDIOGENIC SHOCK 29 0.0020
223 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 59 0.0020
224 ALLERGIC REACTION TO EXCIPIENT 4 0.0020
225 GASTROINTESTINAL TUBE INSERTION 5 0.0020
226 CIRCULATORY COLLAPSE 34 0.0020
227 TYPE 1 DIABETES MELLITUS 12 0.0020
228 VARICES OESOPHAGEAL 6 0.0020
229 SEROTONIN SYNDROME 38 0.0020
230 HYPERKALAEMIA 67 0.0019
231 BLOOD PRESSURE DIASTOLIC DECREASED 14 0.0019
232 RIGHT VENTRICULAR FAILURE 13 0.0019
233 CEREBELLAR SYNDROME 4 0.0018
234 NOSOCOMIAL INFECTION 4 0.0018
235 ARTERIOSCLEROSIS CORONARY ARTERY 12 0.0018
236 ATRIOVENTRICULAR BLOCK 14 0.0018
237 IRON DEFICIENCY 8 0.0018
238 TACHYPNOEA 24 0.0018
239 VASCULAR DEVICE INFECTION 8 0.0018
240 PERIARTHRITIS 4 0.0018
241 ENDOCARDITIS 9 0.0018
242 DIZZINESS POSTURAL 17 0.0018
243 CEREBRAL ISCHAEMIA 9 0.0017
244 BUNDLE BRANCH BLOCK RIGHT 8 0.0017
245 VITAMIN B12 DEFICIENCY 7 0.0017
246 HYPOMAGNESAEMIA 24 0.0017
247 HYPERTENSIVE CRISIS 19 0.0017
248 PULSELESS ELECTRICAL ACTIVITY 7 0.0017
249 SYNCOPE 166 0.0017
250 AORTIC VALVE INCOMPETENCE 7 0.0016
251 HAEMATOLOGICAL INFECTION 4 0.0016
252 BODY TEMPERATURE ABNORMAL 3 0.0016
253 TACHYCARDIA 144 0.0016
254 PULMONARY CONGESTION 21 0.0016
255 PULMONARY ARTERIAL HYPERTENSION 23 0.0016
256 CONJUNCTIVAL HAEMORRHAGE 6 0.0016
257 ACUTE CORONARY SYNDROME 13 0.0016
258 OFF LABEL USE 1369 0.0016
259 ARRHYTHMIA 74 0.0016
260 PALPITATIONS 182 0.0016
261 BLOOD CHLORIDE DECREASED 4 0.0015
262 BRONCHOSPASM 22 0.0015
263 RESPIRATORY TRACT INFECTION 40 0.0015
264 DRUG LEVEL ABOVE THERAPEUTIC 7 0.0015
265 MELAENA 33 0.0015
266 HEART RATE INCREASED 148 0.0015
267 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 6 0.0015
268 FLUID RETENTION 74 0.0015
269 EUGLYCAEMIC DIABETIC KETOACIDOSIS 6 0.0015
270 RESPIRATION ABNORMAL 10 0.0014
271 AKINESIA 3 0.0014
272 EXTRASYSTOLES 10 0.0014
273 PHARYNGEAL SWELLING 14 0.0014
274 HEPATOMEGALY 14 0.0014
275 HYPERVOLAEMIA 7 0.0014
276 OXYGEN SATURATION ABNORMAL 4 0.0014
277 ANAEMIA MACROCYTIC 3 0.0014
278 OEDEMA PERIPHERAL 170 0.0014
279 VISUAL FIELD DEFECT 10 0.0014
280 RALES 8 0.0014
281 IMMOBILE 6 0.0014
282 PSYCHIATRIC SYMPTOM 10 0.0014
283 PERIORBITAL OEDEMA 7 0.0013
284 CARDIOTOXICITY 12 0.0013
285 BLOOD LACTIC ACID INCREASED 7 0.0013
286 CENTRAL VENOUS CATHETERISATION 4 0.0013
287 SUDDEN DEATH 14 0.0013
288 VITREOUS FLOATERS 13 0.0013
289 HYPOCALCAEMIA 25 0.0013
290 LOSS OF CONTROL OF LEGS 5 0.0013
291 CORONARY ARTERY OCCLUSION 18 0.0013
292 DIABETIC FOOT 4 0.0013
293 HYPERTRANSAMINASAEMIA 9 0.0013
294 THERAPEUTIC PRODUCT INEFFECTIVE 5 0.0013
295 FLANK PAIN 12 0.0013
296 OESOPHAGEAL PAIN 5 0.0013
297 HYPERLIPIDAEMIA 15 0.0013
298 BLOOD UREA INCREASED 21 0.0013
299 COLD SWEAT 22 0.0012
300 MYDRIASIS 16 0.0012
301 INTERNATIONAL NORMALISED RATIO DECREASED 5 0.0012
302 VITAMIN D DEFICIENCY 12 0.0012
303 MYOCARDIAL ISCHAEMIA 14 0.0012
304 JOINT DISLOCATION 13 0.0012
305 MYOSITIS 11 0.0012
306 GOITRE 5 0.0012
307 PRODUCT PRESCRIBING ERROR 29 0.0012
308 TRANSAMINASES INCREASED 27 0.0012
309 BLOOD IMMUNOGLOBULIN G DECREASED 3 0.0012
310 RESTLESSNESS 44 0.0012
311 RHABDOMYOLYSIS 50 0.0012
312 ANGIOEDEMA 53 0.0012
313 SPINAL PAIN 14 0.0012
314 TENDON PAIN 9 0.0012
315 INFUSION SITE ERYTHEMA 10 0.0012
316 ABDOMINAL INFECTION 3 0.0012
317 PULMONARY TUBERCULOSIS 5 0.0012
318 ECCHYMOSIS 8 0.0012
319 BLOOD CREATININE ABNORMAL 4 0.0012
320 DUODENAL ULCER 8 0.0011
321 OBESITY 18 0.0011
322 BLOOD PRESSURE DECREASED 75 0.0011
323 HYPOKALAEMIA 52 0.0011
324 METABOLIC ACIDOSIS 36 0.0011
325 PRE-EXISTING CONDITION IMPROVED 7 0.0011
326 CHEST PAIN 206 0.0011
327 HEART RATE IRREGULAR 25 0.0011
328 PULMONARY HYPERTENSION 23 0.0011
329 HYPOTONIA 11 0.0011
330 HYDROCEPHALUS 6 0.0011
331 TENDONITIS 17 0.0011
332 HALLUCINATION, VISUAL 23 0.0011
333 BODY TEMPERATURE INCREASED 22 0.0011
334 HAEMATEMESIS 27 0.0011
335 DERMATITIS CONTACT 12 0.0011
336 LEUKOCYTOSIS 19 0.0010
337 MENINGITIS 7 0.0010
338 INTENTIONAL OVERDOSE 67 0.0010
339 FOOD ALLERGY 8 0.0010
340 RESPIRATORY SYNCYTIAL VIRUS INFECTION 9 0.0010
341 AGRANULOCYTOSIS 19 0.0010
342 DIABETES MELLITUS INADEQUATE CONTROL 18 0.0010
343 COVID-19 PNEUMONIA 12 0.0010
344 IDIOPATHIC PULMONARY FIBROSIS 4 0.0010
345 PHOTOPHOBIA 19 0.0010
346 BLOOD CREATINE PHOSPHOKINASE INCREASED 29 0.0010
347 BLOOD CREATININE INCREASED 65 0.0010
348 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 6 0.0010
349 DEPRESSED LEVEL OF CONSCIOUSNESS 39 0.0010
350 ATRIAL FIBRILLATION 96 0.0010
351 CARDIOMEGALY 12 0.0010
352 ARTHRITIS BACTERIAL 4 0.0010
353 INITIAL INSOMNIA 10 0.0010
354 HYPERTHYROIDISM 14 0.0010
355 MAJOR DEPRESSION 7 0.0010
356 BLOOD PRESSURE ABNORMAL 19 0.0010
357 GASTRITIS 25 0.0009
358 FIBROMYALGIA 23 0.0009
359 PNEUMOTHORAX 15 0.0009
360 ACUTE KIDNEY INJURY 144 0.0009
361 ATELECTASIS 9 0.0009
362 TENSION HEADACHE 4 0.0009
363 POOR QUALITY SLEEP 20 0.0009
364 BRUXISM 5 0.0009
365 STAPHYLOCOCCAL BACTERAEMIA 4 0.0009
366 TENDON DISORDER 6 0.0009
367 TROPONIN INCREASED 7 0.0009
368 MULTIPLE ORGAN DYSFUNCTION SYNDROME 26 0.0009
369 URINE OUTPUT DECREASED 8 0.0009
370 FAECALOMA 5 0.0009
371 CATHETERISATION CARDIAC 4 0.0009
372 BLOOD SODIUM DECREASED 17 0.0009
373 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 7 0.0009
374 FRACTURE 17 0.0009
375 SUICIDE ATTEMPT 54 0.0009
376 GENERALISED OEDEMA 11 0.0009
377 IMPAIRED GASTRIC EMPTYING 12 0.0009
378 SHOCK 20 0.0009
379 MYASTHENIA GRAVIS 7 0.0009
380 AORTIC STENOSIS 3 0.0009
381 ASPHYXIA 7 0.0009
382 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 47 0.0009
383 HYPOVOLAEMIA 5 0.0009
384 INFUSION SITE PAIN 11 0.0009
385 ARTERIOSCLEROSIS 8 0.0008
386 PHOTOSENSITIVITY REACTION 14 0.0008
387 VISUAL IMPAIRMENT 105 0.0008
388 SKIN ABRASION 4 0.0008
389 DYSPNOEA 478 0.0008
390 ENDOMETRIOSIS 4 0.0008
391 CARDIAC PACEMAKER INSERTION 5 0.0008
392 GOUT 15 0.0008
393 ORAL CANDIDIASIS 11 0.0008
394 HYPOVOLAEMIC SHOCK 4 0.0008
395 HYPERCHOLESTEROLAEMIA 8 0.0008
396 CORONARY ARTERY DISEASE 25 0.0008
397 CONTUSION 79 0.0008
398 HYPONATRAEMIA 46 0.0008
399 LIP SWELLING 27 0.0008
400 MULTI-ORGAN FAILURE 14 0.0008
401 DISABILITY 16 0.0008
402 PYELONEPHRITIS 7 0.0008
403 INFUSION SITE EXTRAVASATION 5 0.0008
404 PNEUMONIA ASPIRATION 20 0.0008
405 PREMATURE BABY 24 0.0008
406 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 7 0.0008
407 DYSLIPIDAEMIA 4 0.0008
408 CARDIAC ARREST 65 0.0008
409 SLEEP APNOEA SYNDROME 15 0.0008
410 DRUG LEVEL INCREASED 13 0.0008
411 MYOCARDITIS 9 0.0008
412 NIGHTMARE 27 0.0008
413 RENAL FAILURE ACUTE 33 0.0008
414 PERIPHERAL VASCULAR DISORDER 4 0.0008
415 DYSARTHRIA 29 0.0008
416 DIPLOPIA 20 0.0008
417 PETECHIAE 8 0.0008
418 HYPOGLYCAEMIA 37 0.0008
419 FOOD CRAVING 4 0.0008
420 ATAXIA 9 0.0008
421 HYPOKINESIA 11 0.0008
422 COMPLICATION ASSOCIATED WITH DEVICE 11 0.0008
423 MUSCULOSKELETAL DISCOMFORT 13 0.0008
424 CHEST DISCOMFORT 77 0.0008
425 AZOTAEMIA 3 0.0008
426 ERYTHEMA MULTIFORME 7 0.0007
427 MIDDLE INSOMNIA 14 0.0007
428 LETHARGY 43 0.0007
429 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 39 0.0007
430 GASTROINTESTINAL MOTILITY DISORDER 4 0.0007
431 OVERWEIGHT 4 0.0007
432 SCHIZOPHRENIA 9 0.0007
433 OEDEMA 40 0.0007
434 GENERAL PHYSICAL CONDITION ABNORMAL 5 0.0007
435 DIZZINESS 366 0.0007
436 MANIA 12 0.0007
437 ANAPHYLACTOID REACTION 3 0.0007
438 SPINAL COMPRESSION FRACTURE 6 0.0007
439 GENERALISED TONIC-CLONIC SEIZURE 12 0.0007
440 ILEUS 9 0.0007
441 PLEURAL EFFUSION 44 0.0007
442 PSYCHOMOTOR HYPERACTIVITY 12 0.0007
443 MIGRAINE 69 0.0007
444 LARGE INTESTINE POLYP 5 0.0007
445 AGEUSIA 18 0.0007
446 INSURANCE ISSUE 11 0.0007
447 THROMBOTIC MICROANGIOPATHY 7 0.0007
448 ATRIAL SEPTAL DEFECT 6 0.0007
449 OXYGEN SATURATION DECREASED 40 0.0007
450 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 24 0.0007
451 HYPOXIA 25 0.0007
452 BLOOD PRESSURE FLUCTUATION 17 0.0007
453 SKIN TOXICITY 4 0.0007
454 ABSCESS LIMB 3 0.0007
455 NEUTROPENIC SEPSIS 5 0.0007
456 EMPHYSEMA 7 0.0007
457 URINARY RETENTION 23 0.0007
458 DRUG LEVEL DECREASED 7 0.0007
459 GENERAL PHYSICAL HEALTH DETERIORATION 79 0.0007
460 DYSURIA 25 0.0007
461 TEMPERATURE INTOLERANCE 7 0.0007
462 CARDIAC DISORDER 63 0.0007
463 CARDIAC FAILURE CONGESTIVE 54 0.0007
464 CARDIOVASCULAR DISORDER 17 0.0007
465 FEAR 18 0.0007
466 INTERNATIONAL NORMALISED RATIO INCREASED 19 0.0007
467 PEMPHIGOID 5 0.0007
468 COAGULOPATHY 11 0.0007
469 ADRENAL INSUFFICIENCY 8 0.0007
470 FOETAL GROWTH RESTRICTION 4 0.0007
471 VERTIGO 40 0.0007
472 CEREBRAL INFARCTION 16 0.0007
473 RESPIRATORY DEPRESSION 8 0.0007
474 SPINAL OPERATION 8 0.0006
475 TENDON RUPTURE 8 0.0006
476 INTENTIONAL SELF-INJURY 13 0.0006
477 ARTERIAL OCCLUSIVE DISEASE 5 0.0006
478 CYANOSIS 10 0.0006
479 INFUSION SITE SWELLING 4 0.0006
480 DELIRIUM 22 0.0006
481 GAMMA-GLUTAMYLTRANSFERASE INCREASED 14 0.0006
482 BLOOD ALBUMIN DECREASED 5 0.0006
483 SLEEP DISORDER 44 0.0006
484 RENAL IMPAIRMENT 52 0.0006
485 HIATUS HERNIA 8 0.0006
486 LACTIC ACIDOSIS 20 0.0006
487 IMPAIRED DRIVING ABILITY 7 0.0006
488 AUTOIMMUNE DISORDER 6 0.0006
489 ANAEMIA 117 0.0006
490 REFUSAL OF TREATMENT BY PATIENT 4 0.0006
491 BRADYPHRENIA 4 0.0006
492 NEOPLASM 7 0.0006
493 PERICARDIAL EFFUSION 14 0.0006
494 CORONAVIRUS INFECTION 4 0.0006
495 C-REACTIVE PROTEIN INCREASED 22 0.0006
496 CARDIO-RESPIRATORY ARREST 25 0.0006
497 PSORIASIS 78 0.0006
498 UPPER GASTROINTESTINAL HAEMORRHAGE 10 0.0006
499 INTENTIONAL PRODUCT MISUSE 52 0.0006
500 LOWER RESPIRATORY TRACT INFECTION 27 0.0006
501 SENSATION OF FOREIGN BODY 5 0.0006
502 SEPSIS 66 0.0006
503 PNEUMONITIS 16 0.0006
504 CARDIAC OPERATION 5 0.0006
505 DISORIENTATION 23 0.0006
506 THERAPEUTIC RESPONSE UNEXPECTED 26 0.0006
507 HAEMATOMA 15 0.0006
508 LABORATORY TEST ABNORMAL 17 0.0006
509 NO THERAPEUTIC RESPONSE 7 0.0006
510 FEBRILE NEUTROPENIA 38 0.0006
511 DRUG PRESCRIBING ERROR 11 0.0006
512 NEUROTOXICITY 10 0.0006
513 METASTASES TO LIVER 10 0.0006
514 ASTHMA 64 0.0006
515 ULCER 9 0.0006
516 BLOOD POTASSIUM DECREASED 17 0.0006
517 RETCHING 12 0.0006
518 LOSS OF LIBIDO 5 0.0006
519 HAEMATURIA 19 0.0006
520 GLYCOSYLATED HAEMOGLOBIN INCREASED 14 0.0006
521 PARAESTHESIA ORAL 8 0.0006
522 SWELLING FACE 36 0.0006
523 LUNG DISORDER 27 0.0006
524 MATERNAL EXPOSURE DURING PREGNANCY 49 0.0005
525 FLUID OVERLOAD 8 0.0005
526 LIMB DISCOMFORT 17 0.0005
527 HYPERGLYCAEMIA 20 0.0005
528 PANIC ATTACK 20 0.0005
529 GASTROENTERITIS 8 0.0005
530 UNDERDOSE 40 0.0005
531 UTERINE LEIOMYOMA 4 0.0005
532 FEELING ABNORMAL 131 0.0005
533 FOETAL EXPOSURE DURING PREGNANCY 44 0.0005
534 PRODUCT DISTRIBUTION ISSUE 5 0.0005
535 VISION BLURRED 74 0.0005
536 INTERSTITIAL LUNG DISEASE 26 0.0005
537 PERICARDITIS 9 0.0005
538 NEPHROPATHY 5 0.0005
539 DEAFNESS 14 0.0005
540 AGITATION 39 0.0005
541 COVID-19 93 0.0005
542 MENTAL DISORDER 23 0.0005
543 HOSPITALISATION 81 0.0005
544 INTENTIONAL DOSE OMISSION 15 0.0005
545 AORTIC ANEURYSM 4 0.0005
546 HYPERTHERMIA 4 0.0005
547 MEDICATION ERROR 29 0.0005
548 PULMONARY FIBROSIS 10 0.0005
549 ACUTE RESPIRATORY FAILURE 10 0.0005
550 CONCUSSION 4 0.0005
551 BRONCHOPULMONARY ASPERGILLOSIS 4 0.0005
552 LIVER FUNCTION TEST ABNORMAL 15 0.0005
553 HYPERHIDROSIS 66 0.0005
554 SPLENOMEGALY 6 0.0005
555 SURGERY 30 0.0005
556 THERAPY CHANGE 5 0.0005
557 BRADYKINESIA 3 0.0005
558 SYSTEMIC LUPUS ERYTHEMATOSUS 18 0.0005
559 SEPTIC SHOCK 22 0.0005
560 HEAD INJURY 16 0.0005
561 RENAL CYST 4 0.0005
562 TINNITUS 23 0.0005
563 BLINDNESS UNILATERAL 7 0.0005
564 STENT PLACEMENT 4 0.0005
565 NOCTURIA 6 0.0005
566 SHOCK HAEMORRHAGIC 4 0.0005
567 POLYURIA 4 0.0005
568 HICCUPS 4 0.0005
569 IMPAIRED QUALITY OF LIFE 7 0.0005
570 EYE DISORDER 16 0.0005
571 DRUG INTOLERANCE 47 0.0005
572 PRODUCT AVAILABILITY ISSUE 11 0.0005
573 PANCYTOPENIA 27 0.0005
574 MENSTRUAL DISORDER 4 0.0005
575 RENAL FAILURE 64 0.0005
576 INTENTIONAL PRODUCT USE ISSUE 42 0.0005
577 BLOOD PRESSURE INCREASED 73 0.0005
578 CANDIDA INFECTION 8 0.0005
579 MUSCLE ATROPHY 6 0.0005
580 ANAPHYLACTIC REACTION 26 0.0005
581 PULMONARY MASS 7 0.0005
582 DRY MOUTH 38 0.0005
583 RESPIRATORY DISORDER 14 0.0005
584 HEREDITARY ANGIOEDEMA 5 0.0005
585 BLOOD MAGNESIUM DECREASED 4 0.0005
586 HYPERTENSION 98 0.0005
587 UNEVALUABLE EVENT 35 0.0005
588 CARDIAC MURMUR 4 0.0005
589 HYSTERECTOMY 4 0.0005
590 LOSS OF CONSCIOUSNESS 59 0.0005
591 WEIGHT INCREASED 103 0.0005
592 DISCOMFORT 28 0.0005
593 JOINT STIFFNESS 12 0.0005
594 TREATMENT NONCOMPLIANCE 25 0.0005
595 STAPHYLOCOCCAL INFECTION 15 0.0005
596 GASTROINTESTINAL PAIN 5 0.0005
597 THYROID DISORDER 7 0.0005
598 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
599 ABORTION SPONTANEOUS 18 0.0004
600 FACIAL PAIN 4 0.0004
601 THIRST 8 0.0004
602 QUALITY OF LIFE DECREASED 6 0.0004
603 PRODUCT USE ISSUE 84 0.0004
604 MALAISE 194 0.0004
605 ASTHENIA 166 0.0004
606 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 3 0.0004
607 PALLOR 12 0.0004
608 PRODUCTIVE COUGH 21 0.0004
609 CONFUSIONAL STATE 71 0.0004
610 FATIGUE 342 0.0004
611 BONE DISORDER 8 0.0004
612 RESPIRATORY FAILURE 32 0.0004
613 MOVEMENT DISORDER 14 0.0004
614 COUGH 122 0.0004
615 HAEMOPTYSIS 12 0.0004
616 PERIPHERAL SWELLING 66 0.0004
617 FALL 142 0.0004
618 HEPATIC CIRRHOSIS 8 0.0004
619 SQUAMOUS CELL CARCINOMA 4 0.0004
620 FEELING HOT 26 0.0004
621 SPUTUM DISCOLOURED 4 0.0004
622 BLOOD IRON DECREASED 5 0.0004
623 GASTRIC ULCER 8 0.0004
624 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 4 0.0004
625 GAIT INABILITY 14 0.0004
626 URTICARIA 70 0.0004
627 TREMOR 69 0.0004
628 NEPHROLITHIASIS 19 0.0004
629 PRODUCT DISPENSING ERROR 9 0.0004
630 DEHYDRATION 55 0.0004
631 THROMBOCYTOPENIA 46 0.0004
632 HAEMORRHOIDS 8 0.0004
633 CHOKING 8 0.0004
634 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 83 0.0004
635 KIDNEY INFECTION 8 0.0004
636 LIVER INJURY 10 0.0004
637 PARANOIA 7 0.0004
638 CEREBRAL DISORDER 3 0.0004
639 SUICIDAL IDEATION 37 0.0004
640 NIGHT SWEATS 13 0.0004
641 IMMUNODEFICIENCY 6 0.0004
642 EPISTAXIS 30 0.0004
643 PRESCRIBED UNDERDOSE 8 0.0004
644 PANCREATITIS ACUTE 9 0.0004
645 HEADACHE 251 0.0004
646 COMA 19 0.0004
647 HEAD DISCOMFORT 7 0.0004
648 DYSKINESIA 16 0.0004
649 SOMNOLENCE 79 0.0004
650 GALLBLADDER DISORDER 7 0.0004
651 BLISTER 22 0.0004
652 BOWEL MOVEMENT IRREGULARITY 3 0.0004
653 MYALGIA 66 0.0004
654 POOR VENOUS ACCESS 4 0.0004
655 TYPE 2 DIABETES MELLITUS 13 0.0004
656 PNEUMONIA 125 0.0004
657 THERAPY PARTIAL RESPONDER 6 0.0004
658 SWOLLEN TONGUE 12 0.0004
659 MUSCLE SPASMS 70 0.0004
660 URINARY TRACT INFECTION 65 0.0004
661 BEDRIDDEN 5 0.0004
662 ANKYLOSING SPONDYLITIS 5 0.0004
663 ILL-DEFINED DISORDER 23 0.0004
664 SARS-COV-2 TEST POSITIVE 5 0.0004
665 BRONCHITIS 28 0.0004
666 PREMATURE DELIVERY 6 0.0004
667 DYSSTASIA 11 0.0004
668 HEPATIC STEATOSIS 7 0.0004
669 EAR INFECTION 10 0.0004
670 BREAST PAIN 4 0.0004
671 CONDITION AGGRAVATED 114 0.0004
672 TOXICITY TO VARIOUS AGENTS 63 0.0004
673 DECREASED APPETITE 86 0.0004
674 NEURALGIA 9 0.0004
675 THROAT TIGHTNESS 10 0.0004
676 PSORIATIC ARTHROPATHY 15 0.0004
677 ILLNESS 38 0.0004
678 BIPOLAR DISORDER 4 0.0004
679 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 26 0.0004
680 WEIGHT DECREASED 101 0.0004
681 VIRAL INFECTION 12 0.0004
682 MENTAL STATUS CHANGES 10 0.0004
683 EPILEPSY 11 0.0004
684 STEVENS-JOHNSON SYNDROME 8 0.0004
685 OBSTRUCTIVE AIRWAYS DISORDER 4 0.0004
686 MALNUTRITION 4 0.0004
687 CARPAL TUNNEL SYNDROME 5 0.0004
688 THERAPY NON-RESPONDER 16 0.0004
689 FACE OEDEMA 6 0.0004
690 BLOOD CALCIUM DECREASED 4 0.0004
691 PYREXIA 123 0.0004
692 DEVICE OCCLUSION 5 0.0004
693 HEMIPARESIS 6 0.0004
694 REBOUND EFFECT 4 0.0004
695 DISTURBANCE IN ATTENTION 19 0.0004
696 CHOLECYSTECTOMY 4 0.0003
697 SUBDURAL HAEMATOMA 5 0.0003
698 PARALYSIS 5 0.0003
699 NAUSEA 276 0.0003
700 DISEASE PROGRESSION 41 0.0003
701 ABDOMINAL DISTENSION 36 0.0003
702 ALANINE AMINOTRANSFERASE INCREASED 21 0.0003
703 SINUSITIS 35 0.0003
704 ASCITES 10 0.0003
705 WHITE BLOOD CELL COUNT INCREASED 13 0.0003
706 MYOCARDIAL INFARCTION 59 0.0003
707 TREATMENT FAILURE 28 0.0003
708 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
709 DYSPHAGIA 32 0.0003
710 POLLAKIURIA 14 0.0003
711 POLYNEUROPATHY 4 0.0003
712 BLOOD BILIRUBIN INCREASED 9 0.0003
713 HOT FLUSH 25 0.0003
714 THERAPEUTIC RESPONSE SHORTENED 11 0.0003
715 PRODUCT STORAGE ERROR 29 0.0003
716 SWELLING 31 0.0003
717 RESPIRATORY DISTRESS 9 0.0003
718 BLOOD THYROID STIMULATING HORMONE INCREASED 3 0.0003
719 ECZEMA 17 0.0003
720 CONJUNCTIVITIS 6 0.0003
721 GASTROINTESTINAL HAEMORRHAGE 27 0.0003
722 GASTROOESOPHAGEAL REFLUX DISEASE 26 0.0003
723 ADVERSE DRUG REACTION 29 0.0003
724 EXPOSURE DURING PREGNANCY 20 0.0003
725 BACTERIAL INFECTION 6 0.0003
726 HAIR COLOUR CHANGES 4 0.0003
727 CONSTIPATION 70 0.0003
728 INTERVERTEBRAL DISC PROTRUSION 7 0.0003
729 MOBILITY DECREASED 23 0.0003
730 ASPARTATE AMINOTRANSFERASE INCREASED 17 0.0003
731 BRAIN FOG 5 0.0003
732 DRUG-INDUCED LIVER INJURY 10 0.0003
733 DERMATITIS ALLERGIC 4 0.0003
734 PAIN IN JAW 9 0.0003
735 MUSCULAR WEAKNESS 36 0.0003
736 BRAIN OEDEMA 4 0.0003
737 BLOOD URINE PRESENT 6 0.0003
738 CHRONIC KIDNEY DISEASE 24 0.0003
739 HYPERSOMNIA 9 0.0003
740 HEPATIC CYTOLYSIS 4 0.0003
741 VOMITING 147 0.0003
742 THROMBOSIS 25 0.0003
743 HERNIA 6 0.0003
744 ERUCTATION 6 0.0003
745 PRESCRIBED OVERDOSE 6 0.0003
746 SKIN ULCER 8 0.0003
747 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
748 AMNESIA 20 0.0003
749 PLATELET COUNT INCREASED 4 0.0003
750 SKIN DISCOLOURATION 14 0.0003
751 RECTAL HAEMORRHAGE 13 0.0003
752 BLADDER DISORDER 3 0.0003
753 JAUNDICE 8 0.0003
754 ABDOMINAL PAIN UPPER 61 0.0003
755 FEEDING DISORDER 6 0.0003
756 PULMONARY EMBOLISM 28 0.0003
757 DISEASE RECURRENCE 14 0.0003
758 THERAPY INTERRUPTED 21 0.0003
759 AKATHISIA 4 0.0003
760 GINGIVAL BLEEDING 4 0.0003
761 OVERDOSE 63 0.0003
762 GYNAECOMASTIA 9 0.0003
763 HYPERSENSITIVITY 54 0.0003
764 INFLAMMATION 15 0.0003
765 RESPIRATORY ARREST 8 0.0003
766 BONE PAIN 17 0.0003
767 HAEMATOCHEZIA 16 0.0003
768 DIVERTICULITIS 8 0.0003
769 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 52 0.0003
770 DEVICE DEFECTIVE 5 0.0003
771 NEUTROPENIA 39 0.0003
772 WOUND 8 0.0003
773 RASH MACULAR 10 0.0003
774 SEIZURE 33 0.0003
775 DEPRESSION 65 0.0003
776 DEPRESSED MOOD 15 0.0003
777 INFECTION 41 0.0003
778 LYMPHOCYTE COUNT DECREASED 5 0.0003
779 PRODUCT USE IN UNAPPROVED INDICATION 70 0.0003
780 DRUG ERUPTION 5 0.0003
781 GASTROINTESTINAL DISORDER 25 0.0003
782 ANXIETY 79 0.0003
783 ANOSMIA 4 0.0003
784 NEEDLE ISSUE 8 0.0003
785 NEUROPATHY PERIPHERAL 26 0.0003
786 CHILLS 32 0.0003
787 BLINDNESS 11 0.0003
788 EYE SWELLING 10 0.0003
789 OSTEOPOROSIS 11 0.0003
790 HYPOAESTHESIA 40 0.0003
791 APHASIA 8 0.0003
792 ARTHRALGIA 110 0.0003
793 TOXIC EPIDERMAL NECROLYSIS 4 0.0003
794 DRUG DISPENSING ERROR 4 0.0003
795 PAIN IN EXTREMITY 77 0.0003
796 PARAESTHESIA 41 0.0003
797 DIARRHOEA 168 0.0003
798 UPPER RESPIRATORY TRACT INFECTION 12 0.0003
799 INSOMNIA 69 0.0003
800 ANKLE FRACTURE 4 0.0003
801 ERYTHEMA 53 0.0003
802 DYSTONIA 5 0.0003
803 LIMB INJURY 7 0.0003
804 BLOOD CHOLESTEROL INCREASED 12 0.0003
805 BASAL CELL CARCINOMA 4 0.0003
806 PRODUCT DOSE OMISSION ISSUE 75 0.0003
807 WHEEZING 15 0.0003
808 ACTIVITIES OF DAILY LIVING IMPAIRED 5 0.0003
809 HAEMATOCRIT DECREASED 5 0.0003
810 HALLUCINATION 19 0.0003
811 ACCIDENT 3 0.0003
812 GAIT DISTURBANCE 48 0.0003
813 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 12 0.0002
814 DIABETES MELLITUS 19 0.0002
815 DYSPEPSIA 24 0.0002
816 RIB FRACTURE 5 0.0002
817 CEREBROVASCULAR ACCIDENT 41 0.0002
818 CELLULITIS 12 0.0002
819 OROPHARYNGEAL PAIN 22 0.0002
820 TRANSIENT ISCHAEMIC ATTACK 8 0.0002
821 COGNITIVE DISORDER 11 0.0002
822 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 4 0.0002
823 HYPOPHAGIA 6 0.0002
824 RASH 102 0.0002
825 ERECTILE DYSFUNCTION 6 0.0002
826 DRUG RESISTANCE 6 0.0002
827 IRRITABLE BOWEL SYNDROME 5 0.0002
828 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 6 0.0002
829 HEPATIC FAILURE 7 0.0002
830 ABDOMINAL PAIN 54 0.0002
831 LACRIMATION INCREASED 7 0.0002
832 BALANCE DISORDER 20 0.0002
833 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
834 FAECES DISCOLOURED 5 0.0002
835 MUCOSAL INFLAMMATION 6 0.0002
836 DRUG INEFFECTIVE 302 0.0002
837 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
838 SPEECH DISORDER 12 0.0002
839 EOSINOPHILIA 4 0.0002
840 DRUG ABUSE 19 0.0002
841 BACK PAIN 53 0.0002
842 AMENORRHOEA 4 0.0002
843 HEPATOTOXICITY 5 0.0002
844 NERVOUS SYSTEM DISORDER 7 0.0002
845 HAEMOGLOBIN DECREASED 23 0.0002
846 ORAL PAIN 5 0.0002
847 GASTROENTERITIS VIRAL 4 0.0002
848 NASAL CONGESTION 13 0.0002
849 OSTEOMYELITIS 4 0.0002
850 DRUG EFFECT INCOMPLETE 8 0.0002
851 ACUTE HEPATIC FAILURE 3 0.0002
852 HYPOTHYROIDISM 7 0.0002
853 SKIN LESION 6 0.0002
854 MEMORY IMPAIRMENT 30 0.0002
855 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
856 BLOOD GLUCOSE INCREASED 41 0.0002
857 ABNORMAL DREAMS 6 0.0002
858 NASOPHARYNGITIS 40 0.0002
859 BLOOD GLUCOSE ABNORMAL 4 0.0002
860 PRURITUS 83 0.0002
861 INFLUENZA 24 0.0002
862 NECK PAIN 12 0.0002
863 THINKING ABNORMAL 4 0.0002
864 ABDOMINAL DISCOMFORT 36 0.0002
865 BLOOD TEST ABNORMAL 3 0.0002
866 DRUG DOSE OMISSION 35 0.0002
867 VISUAL ACUITY REDUCED 7 0.0002
868 PROTEINURIA 4 0.0002
869 POST PROCEDURAL COMPLICATION 4 0.0002
870 DIABETIC KETOACIDOSIS 5 0.0002
871 VAGINAL HAEMORRHAGE 9 0.0002
872 ENCEPHALOPATHY 5 0.0002
873 SKIN EXFOLIATION 17 0.0002
874 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
875 HAEMORRHAGE 21 0.0002
876 PREGNANCY 4 0.0002
877 INFUSION RELATED REACTION 13 0.0002
878 CEREBRAL HAEMORRHAGE 7 0.0002
879 ADVERSE EVENT 18 0.0002
880 PAIN 118 0.0002
881 MUSCULOSKELETAL PAIN 10 0.0002
882 ARTHRITIS 15 0.0002
883 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
884 ALOPECIA 37 0.0002
885 MOOD SWINGS 6 0.0002
886 ABSCESS 3 0.0002
887 JOINT INJURY 4 0.0002
888 LIVER FUNCTION TEST INCREASED 4 0.0002
889 HYPOACUSIS 8 0.0002
890 RHINORRHOEA 12 0.0002
891 RHEUMATOID ARTHRITIS 21 0.0002
892 DEEP VEIN THROMBOSIS 12 0.0002
893 COLITIS 7 0.0002
894 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
895 BACK DISORDER 3 0.0002
896 PRODUCT PRESCRIBING ISSUE 4 0.0002
897 CHOLELITHIASIS 6 0.0002
898 IRRITABILITY 11 0.0002
899 JOINT SWELLING 22 0.0002
900 FUNGAL INFECTION 6 0.0002
901 FEELING COLD 5 0.0002
902 FLUSHING 18 0.0002
903 RED BLOOD CELL COUNT DECREASED 5 0.0002
904 HERPES ZOSTER 10 0.0002
905 MUSCLE TWITCHING 4 0.0002
906 NEUTROPHIL COUNT DECREASED 7 0.0002
907 BURNING SENSATION 12 0.0002
908 DEVICE MALFUNCTION 12 0.0002
909 DEATH 147 0.0002
910 LUNG NEOPLASM MALIGNANT 7 0.0002
911 PSYCHOTIC DISORDER 5 0.0002
912 RASH ERYTHEMATOUS 8 0.0002
913 EMOTIONAL DISTRESS 20 0.0002
914 OSTEOARTHRITIS 7 0.0002
915 CRYING 6 0.0002
916 INJECTION SITE RASH 5 0.0002
917 DEVICE DISLOCATION 7 0.0002
918 DRY EYE 8 0.0002
919 LEUKOPENIA 8 0.0002
920 LIVER DISORDER 7 0.0002
921 INCORRECT DOSE ADMINISTERED 36 0.0002
922 CONVULSION 9 0.0002
923 CYSTITIS 5 0.0002
924 COLITIS ULCERATIVE 7 0.0002
925 THERAPEUTIC PRODUCT EFFECT DECREASED 7 0.0002
926 COMPLETED SUICIDE 13 0.0002
927 THERAPY CESSATION 8 0.0002
928 ANAPHYLACTIC SHOCK 4 0.0002
929 UNRESPONSIVE TO STIMULI 4 0.0002
930 RASH GENERALISED 4 0.0002
931 DERMATITIS ATOPIC 8 0.0002
932 SKIN DISORDER 5 0.0001
933 RASH PRURITIC 8 0.0001
934 PROCEDURAL PAIN 4 0.0001
935 NEOPLASM PROGRESSION 5 0.0001
936 ROAD TRAFFIC ACCIDENT 6 0.0001
937 LYMPHADENOPATHY 5 0.0001
938 INJECTION SITE BRUISING 11 0.0001
939 DRUG WITHDRAWAL SYNDROME 12 0.0001
940 ACCIDENTAL OVERDOSE 5 0.0001
941 PLATELET COUNT DECREASED 14 0.0001
942 SKIN IRRITATION 6 0.0001
943 DRUG ADMINISTRATION ERROR 4 0.0001
944 FEMUR FRACTURE 4 0.0001
945 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 9 0.0001
946 ABNORMAL BEHAVIOUR 5 0.0001
947 BLOOD GLUCOSE DECREASED 6 0.0001
948 EYE PAIN 7 0.0001
949 FLATULENCE 7 0.0001
950 IMPAIRED HEALING 4 0.0001
951 EXPIRED PRODUCT ADMINISTERED 4 0.0001
952 WITHDRAWAL SYNDROME 5 0.0001
953 ABDOMINAL PAIN LOWER 3 0.0001
954 MALIGNANT NEOPLASM PROGRESSION 12 0.0001
955 STOMATITIS 7 0.0001
956 NERVOUSNESS 6 0.0001
957 PANCREATITIS 6 0.0001
958 DYSGEUSIA 8 0.0001
959 RENAL DISORDER 5 0.0001
960 DRY SKIN 14 0.0001
961 PRODUCT SUBSTITUTION ISSUE 6 0.0001
962 HEPATIC ENZYME INCREASED 7 0.0001
963 WHITE BLOOD CELL COUNT DECREASED 11 0.0001
964 THERAPEUTIC RESPONSE DECREASED 6 0.0001
965 EXTRA DOSE ADMINISTERED 4 0.0001
966 ACNE 7 0.0001
967 DEVICE LEAKAGE 4 0.0001
968 INJECTION SITE SWELLING 7 0.0001
969 MUSCULOSKELETAL STIFFNESS 8 0.0001
970 NEOPLASM MALIGNANT 6 0.0001
971 EYE IRRITATION 5 0.0001
972 DYSPHONIA 5 0.0001
973 INFLUENZA LIKE ILLNESS 7 0.0001
974 OCULAR HYPERAEMIA 4 0.0001
975 CATARACT 5 0.0001
976 AGGRESSION 4 0.0001
977 PRODUCT DOSE OMISSION 5 0.0001
978 PROSTATE CANCER 6 0.0001
979 PRODUCT QUALITY ISSUE 10 0.0001
980 INJECTION SITE REACTION 5 0.0001
981 INJECTION SITE ERYTHEMA 9 0.0001
982 ARTHROPATHY 4 0.0001
983 INJECTION SITE PAIN 22 0.0001
984 DEVICE ISSUE 6 0.0001
985 NO ADVERSE EVENT 10 0.0001
986 BLADDER CANCER 3 0.0001
987 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
988 DRUG DEPENDENCE 6 0.0000